Pharmacological Blockade of Hypoxia-Driven Autophagy: A Therapeutic Strategy to Limit Endothelial Activation and Thrombosis
ACS Pharmacology & Translational Science · 14.08.2026 · 9 (8) · 2184-2197
DOI: 10.1021/acsptsci.5c00770 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Pharmacology & Translational Science, online erschienen am 29.07.2026. Verfasst von Propanna Bandyopadhyay und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Sciences, BITS Pilani, Pilani Campus, Rajasthan 333031, India. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 87 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Department of Biotechnology, Ministry of Science and Technology, India, Life Sciences Research Board, Birla Institute of Technology and Science, Pilani.
Abstract (Originalsprache)
Thrombosis, a major underlying cause of cardiovascular disorders, is frequently initiated by endothelial cell (EC) activation, which facilitates platelet adhesion and subsequent clot formation. Although vascular injury is a well-established trigger, accumulating evidence implicates hypoxia as an additional determinant of thrombus development. In our previous study, we demonstrated that hypoxia associated with high altitude can promote autophagy-induced platelet aggregation. However, the contribution of ECs to such thrombosis under comparable hypoxic conditions (10%) remains poorly understood. In this study, using ECs isolated from rat aorta ex vivo, we show that hypoxia-inducible factor-1 alpha (HIF-1α), a key transcription factor, regulates autophagy and subsequent EC activation. Importantly, pharmacological inhibition of HIF-1α-mediated autophagy, repositioning the FDA-approved drug chloroquine (CQ), led to attenuated expression of P-Selectin, ICAM1, VCAM1 and consequent reduced platelet adhesion to ECs. Further mechanistic analysis revealed that autophagy modulates the NF-κB signaling pathway, in which P65 transcriptionally regulates the adhesion molecules ICAM1 and VCAM1 by binding to their upstream promoter elements under hypoxic conditions. In addition, using a rat IVC ligation model, we found that CQ not only attenuates thrombus formation but also suppresses VCAM1 expression, validating its antithrombotic potential. In summary, our findings suggest that hypoxia-induced HIF-1α activation promotes an autophagy-dependent NF-κB signaling cascade, thereby contributing to endothelial activation and thrombus formation. Furthermore, CQ’s ability to disrupt this pathway underscores the therapeutic potential of targeting endothelial autophagy to mitigate hypoxia-associated thrombosis.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biological Sciences, BITS Pilani, Pilani Campus, Rajasthan 333031, India.
- Department of Pharmacy, BITS Pilani, Pilani Campus, Rajasthan 333031, India.
ORCID-Profile: Pragati Ramesh Kumbhar, Yash T Katakia, Sudeshna Mukherjee, Gautam Singhvi
Förderung
- Department of Biotechnology, Ministry of Science and Technology, India
- Life Sciences Research Board
- Birla Institute of Technology and Science, Pilani
Zitieren
APA
Bandyopadhyay, P., Kumbhar, P. R., Katakia, Y. T., Majumder, S., Mukherjee, S., Singhvi, G., & Chowdhury, R. (2026). Pharmacological Blockade of Hypoxia-Driven Autophagy: A Therapeutic Strategy to Limit Endothelial Activation and Thrombosis. ACS Pharmacology & Translational Science, 9(8), 2184-2197. https://doi.org/10.1021/acsptsci.5c00770
Vancouver
Bandyopadhyay P, Kumbhar PR, Katakia YT, Majumder S, Mukherjee S, Singhvi G, et al. Pharmacological Blockade of Hypoxia-Driven Autophagy: A Therapeutic Strategy to Limit Endothelial Activation and Thrombosis. ACS Pharmacology & Translational Science. 2026;9(8):2184-2197. doi:10.1021/acsptsci.5c00770
BibTeX
@article{Bandyopadhyay2026,
author = {Bandyopadhyay, Propanna and Kumbhar, Pragati Ramesh and Katakia, Yash T and Majumder, Syamantak and Mukherjee, Sudeshna and Singhvi, Gautam and Chowdhury, Rajdeep},
title = {Pharmacological Blockade of Hypoxia-Driven Autophagy: A Therapeutic Strategy to Limit Endothelial Activation and Thrombosis},
journal = {ACS Pharmacology & Translational Science},
year = {2026},
volume = {9},
number = {8},
pages = {2184--2197},
doi = {10.1021/acsptsci.5c00770}
}
EUVIMED